Woman and Man
- | Country :
- United Kingdom
- Belgium
- United States
- | organs : -
- | Specialty : -
Extract
Multi-center, open-label, non-randomized Phase II study to evaluate the efficacy and safety of OSI-7904L in gastric and GEJ cancers. Those patients who do not derive clinical benefit after two cycles may be switched to a commonly used combination regimen.
Inclusion criteria
- Gastroesophageal Adenocarcinoma ,Gastric Adenocarcinoma